Alzheimer’s Drug Could Equal Federal Government’s Spending on NASA
June 28, 2021
Biogen’s Aduhelm is exceedingly expensive at $56,000. If covered under Medicare, its cost could approach the federal government’s spending on NASA.
“The Alzheimer’s treatment will cost $56,000 per patient, and millions may use it. The result: “crazy numbers” for Medicare.” Read more here.
(Source: Josh Katz, Sarah Kliff and Margot Sanger-Katz, The New York Times, 6/22/21)